{"id":431961,"date":"2026-06-27T05:48:50","date_gmt":"2026-06-27T05:48:50","guid":{"rendered":"https:\/\/www.europesays.com\/pt\/431961\/"},"modified":"2026-06-27T05:48:50","modified_gmt":"2026-06-27T05:48:50","slug":"i3s-inova-no-tratamento-da-leucemia-mieloide-aguda","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/pt\/431961\/","title":{"rendered":"i3S inova no tratamento da leucemia mieloide aguda"},"content":{"rendered":"<p>&#13;<br \/>\n&#13;<br \/>\n&#13;<br \/>\n    &#13;<br \/>\n    &#13;<br \/>\n&#13;<br \/>\n    &#13;<br \/>\n&#13;<br \/>\n    &#13;<br \/>\n&#13;<\/p>\n<p>\ti3S inova no tratamento da leucemia mieloide aguda<\/p>\n<p>\t\t&#13;<\/p>\n<p>&#13;<br \/>\n<a href=\"https:\/\/noticias.up.pt\/cdn-cgi\/content?id=gOOFTU1UkU.KjKl2YAeclffHuGLzsYmoiBUVFeygqEw-1782539327.6332126-1.2.1.1-Y8ckM8KvuqLj8HYGRJTqswqHljbvdmZ5SI6vUufwGp8\" aria-hidden=\"true\" rel=\"nofollow noopener\" style=\"display: none !important; visibility: hidden !important\" target=\"_blank\">&#13;<br \/>\n&#13;<br \/>\n&#13;<\/p>\n<p>\t\t\t\t\t\t\t\t\t\tA combina\u00e7\u00e3o da transferrina com a quimioterapia protege os vasos sangu\u00edneos da medula \u00f3ssea que sustentam a produ\u00e7\u00e3o normal de sangue. (Foto: i3S)<\/p>\n<p>\t\tNova estrat\u00e9gia terap\u00eautica que potencia quimioterapia contra a leucemia mieloide aguda dever\u00e1 ser testada em colabora\u00e7\u00e3o com o IPO Porto.\t\t\t\t\t\t\t\t<\/p>\n<p>\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.europesays.com\/pt\/wp-content\/uploads\/2026\/06\/Cover-Suggestion-scaled.jpg\" alt=\"i3S inova no tratamento da leucemia mieloide aguda\"\/><\/p>\n<p>Pol\u00edtica Cookies e privacidade de dados<\/p>\n<p>&#13;<br \/>\n&#13;<\/p>\n","protected":false},"excerpt":{"rendered":"&#13; &#13; &#13; &#13; &#13; &#13; &#13; &#13; &#13; &#13; i3S inova no tratamento da leucemia mieloide aguda&hellip;\n","protected":false},"author":2,"featured_media":431962,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[86],"tags":[1207,109,19564,116,7304,2172,1173,2196,1208,32,33,117],"class_list":["post-431961","post","type-post","status-publish","format-standard","has-post-thumbnail","category-saude","tag-cancro","tag-ciencia","tag-cooperacao","tag-health","tag-i3s","tag-inovacao","tag-investigacao","tag-leucemia","tag-medicina","tag-portugal","tag-pt","tag-saude"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@pt\/116820506687065208","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/posts\/431961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/comments?post=431961"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/posts\/431961\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/media\/431962"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/media?parent=431961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/categories?post=431961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/pt\/wp-json\/wp\/v2\/tags?post=431961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}